RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies

Precision treatment of cancer requires knowledge on active tumor driving signal transduction pathways to select the optimal effective targeted treatment. Currently only a subset of patients derive clinical benefit from mutation based targeted treatment, due to intrinsic and acquired drug resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Stolpe, Anja, Verhaegh, Wim, Blay, Jean-Yves, Ma, Cynthia X., Pauwels, Patrick, Pegram, Mark, Prenen, Hans, De Ruysscher, Dirk, Saba, Nabil F., Slovin, Susan F., Willard-Gallo, Karen, Husain, Hatim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893109/
https://www.ncbi.nlm.nih.gov/pubmed/33613616
http://dx.doi.org/10.3389/fgene.2020.598118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893109/
https://www.ncbi.nlm.nih.gov/pubmed/33613616
http://dx.doi.org/10.3389/fgene.2020.598118

Ejemplares similares